Accuracy of epidermal growth factor receptor mutation analysis on the basis of small biopsy specimens in patients with nonsmall cell lung cancer

被引：9

作者：

Fujita, Shiro

Mio, Tadashi

Sonobe, Makoto

Kamiyama, Kiyofumi

Masago, Katsuhiro

Miyahara, Ryo

Wada, Hiromi

Mishima, Michiaki

机构：

[1] Kyoto Univ Hosp, Dept Resp Med, Sakyo Ku, Kyoto 6068507, Japan

[2] Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 6068507, Japan

[3] SRL Inc, Tokyo, Japan

来源：

INTERNATIONAL JOURNAL OF CANCER | 2006年 / 119卷 / 07期

关键词：

D O I：

10.1002/ijc.22012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1751 / 1752

页数：2

共 10 条

[1] Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer
Cappuzzo, F
Hirsch, FR
Rossi, E
Bartolini, S
Ceresoli, GL
Bemis, L
Haney, J
Witta, S
Danenberg, K
Domenichini, I
Ludovini, V
Magrini, E
Gregorc, V
Doglioni, C
Sidoni, A
Tonato, M
Franklin, WA
Crino, L
Bunn, PA
Varella-Garcia, M
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (09): : 643 - 655
[2] Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients
Cortes-Funes, H
Gomez, C
Rosell, R
Valero, P
Garcia-Giron, C
Velasco, A
Izquierdo, A
Diz, P
Camps, C
Castellanos, D
Alberola, V
Cardenal, F
Gonzalez-Larriba, JL
Vieitez, JM
Maeztu, I
Sanchez, JJ
Queralt, C
Mayo, C
Mendez, P
Moran, T
Taron, M
[J]. ANNALS OF ONCOLOGY, 2005, 16 (07) : 1081 - 1086
[3] Predictors of the response to gefitinib in refractory non-small cell lung cancer
Kim, KS
Jeong, JY
Kim, YC
Na, KJ
Kim, YH
Ahn, SJ
Baek, SM
Park, CS
Park, CM
Kim, YI
Lim, SC
Park, KO
[J]. CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2244 - 2251
[4] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
Lynch, TJ
Bell, DW
Sordella, R
Gurubhagavatula, S
Okimoto, RA
Brannigan, BW
Harris, PL
Haserlat, SM
Supko, JG
Haluska, FG
Louis, DN
Christiani, DC
Settleman, J
Haber, DA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2129 - 2139
[5] Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence
Mitsudomi, T
Kosaka, T
Endoh, H
Horio, Y
Hida, T
Mori, S
Hatooka, S
Shinoda, M
Takahashi, T
Yatabe, Y
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) : 2513 - 2520
[6] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
Paez, JG
Jänne, PA
Lee, JC
Tracy, S
Greulich, H
Gabriel, S
Herman, P
Kaye, FJ
Lindeman, N
Boggon, TJ
Naoki, K
Sasaki, H
Fujii, Y
Eck, MJ
Sellers, WR
Johnson, BE
Meyerson, M
[J]. SCIENCE, 2004, 304 (5676) : 1497 - 1500
[7] Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer
Rosell, R
Ichinose, Y
Taron, M
Sarries, C
Queralt, C
Mendez, P
Sanchez, JM
Nishiyama, K
Moran, T
Cirauqui, B
Mate, JL
Besse, B
Reguart, N
Perez, M
Sanchez, JJ
[J]. LUNG CANCER, 2005, 50 (01) : 25 - 33
[8] SHIN JY, 2006, INT J CANCER, V118, P963
[9] Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma
Sonobe, M
Manabe, T
Wada, H
Tanaka, F
[J]. BRITISH JOURNAL OF CANCER, 2005, 93 (03) : 355 - 363
[10] Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer
Takano, T
Ohe, Y
Sakamoto, H
Tsuta, K
Matsuno, Y
Tateishi, U
Yamamoto, S
Nokihara, H
Yamamoto, N
Sekine, I
Kunitoh, H
Shibata, T
Sakiyama, T
Yoshida, T
Tamura, T
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6829 - 6837

← 1 →